Predictors for total hospital and cardiology cost claims among patients with atrial fibrillation initiating dabigatran or acenocoumarol in The Netherlands.
Maartje S JacobsM W J van LeentR G TielemanF G A JansmanQ CaoMaarten Jacobus PostmaM van HulstPublished in: Journal of medical economics (2017)
Dabigatran treatment was as a predictor for lower cardiology costs and lower total hospital care costs in AF patients that initiated oral anticoagulation.